A detailed history of Geode Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 27,540,870 shares of GILD stock, worth $2.59 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares
27,540,870
Previous 26,966,449 2.13%
Holding current value
$2.59 Billion
Previous $1.85 Billion 24.77%
% of portfolio
0.19%
Previous 0.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $38.3 Million - $48.2 Million
574,421 Added 2.13%
27,540,870 $2.31 Billion
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $39 Million - $45 Million
617,094 Added 2.34%
26,966,449 $1.85 Billion
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $77 Million - $93.9 Million
1,075,170 Added 4.25%
26,349,355 $1.93 Billion
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $42.4 Million - $48.1 Million
578,546 Added 2.34%
25,274,185 $2.05 Billion
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $35.7 Million - $39 Million
483,003 Added 1.99%
24,695,639 $1.85 Billion
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $34 Million - $38.8 Million
447,585 Added 1.88%
24,212,636 $1.87 Billion
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $6.45 Million - $7.35 Million
-83,426 Reduced 0.35%
23,765,051 $1.97 Billion
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $15.3 Million - $21.9 Million
244,886 Added 1.04%
23,848,477 $2.04 Billion
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $25.7 Million - $29.3 Million
431,016 Added 1.86%
23,603,591 $1.45 Billion
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $27.1 Million - $30.5 Million
468,908 Added 2.07%
23,172,575 $1.43 Billion
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $2.06 Million - $2.58 Million
-35,512 Reduced 0.16%
22,703,667 $1.35 Billion
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $28.6 Million - $32.5 Million
440,695 Added 1.98%
22,739,179 $1.65 Billion
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $25.9 Million - $28 Million
383,163 Added 1.75%
22,298,484 $1.55 Billion
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $79 Million - $86.3 Million
1,244,015 Added 6.02%
21,915,321 $1.51 Billion
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $35.5 Million - $40.6 Million
592,386 Added 2.95%
20,671,306 $1.33 Billion
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $4.36 Million - $4.97 Million
76,942 Added 0.38%
20,078,920 $1.17 Billion
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $20.9 Million - $26.3 Million
336,543 Added 1.71%
20,001,978 $1.26 Billion
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $15.7 Million - $18.2 Million
-217,073 Reduced 1.09%
19,665,435 $1.51 Billion
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $41.2 Million - $52.8 Million
658,471 Added 3.43%
19,882,508 $1.48 Billion
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $33 Million - $36.3 Million
535,813 Added 2.87%
19,224,037 $1.25 Billion
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $19.7 Million - $21.8 Million
315,436 Added 1.72%
18,688,224 $1.18 Billion
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $46.5 Million - $52.2 Million
751,923 Added 4.27%
18,372,788 $1.24 Billion
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $47.1 Million - $52.8 Million
753,800 Added 4.47%
17,620,865 $1.14 Billion
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $50.6 Million - $66 Million
835,915 Added 5.21%
16,867,065 $1.05 Billion
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $6.88 Million - $7.62 Million
96,590 Added 0.61%
16,031,150 $1.24 Billion
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $70.9 Million - $82.7 Million
-1,093,008 Reduced 6.42%
15,934,560 $1.13 Billion
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $85.8 Million - $105 Million
1,178,505 Added 7.44%
17,027,568 $1.28 Billion
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $27 Million - $31.7 Million
379,867 Added 2.46%
15,849,063 $1.13 Billion
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $27.1 Million - $32.1 Million
375,993 Added 2.49%
15,469,196 $1.25 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
15,093,203
15,093,203 $1.07 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.